Drawing for O SANOFI AVENTIS ONCOLOGY

USPTO serial 85094146

O SANOFI AVENTIS ONCOLOGY

Reviewed by CopyMark Law Group

Reg. 4011299Status 710
Filing date
Status date
Registration date
Aug 16, 2011
Examiner
NELSON, EDWARD
Law office
—

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with O SANOFI AVENTIS ONCOLOGY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Susan Upton Douglass

SUSAN UPTON DOUGLASS FROSS ZELNICK LEHRMAN & ZISSU, P.C.4 TIMES SQUARE, 17TH FLOORNEW YORK, NY 10036UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005pharmaceutical preparations for the diagnosis, prevention and treatment of cancerSECTION 8 - CANCELLED—
009computer software for database management in the field of oncology; audio and video recordings in the field of oncologySECTION 8 - CANCELLED—
010radiological apparatus for medical purposes, radiology screens for medical purposesSECTION 8 - CANCELLED—
016printed materials, namely, newsletters, magazines, periodicals, pamphlets, books, and posters distributed in the field of oncologySECTION 8 - CANCELLED—
035promoting the exchange of information and resources within the scientific research and medical communities to achieve advances in the field of healthcare; organizing, promoting and conducting exhibitions for commercial or advertising purposes; consulting with hospitals or doctors on managing an oncology practiceSECTION 8 - CANCELLED—
041educational services for consumers and professionals in the field of oncology, namely, arranging and conducting classes, seminars, programs, conferences, courses and workshops in the fields of oncology and eye care, and instructional materials distributed therewith; conducting online educational exhibitions, displays and interactive exhibits in the field of oncology; providing on-line non-downloadable publications and audio-video materials in the field of oncologySECTION 8 - CANCELLED—
042biological, pharmaceutical and medical research; medical and scientific research, namely, conducting clinical trials in the field of oncology; industrial analysis and research services; conception and development of software, data management softwareSECTION 8 - CANCELLED—
044providing cancer screening services; providing information in the field of cancer prevention, screening, diagnosis and treatment; consultation concerning oncology, namely, awareness programs and disease management programsSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 23, 2018C8..CANCELLED SEC. 8 (6-YR)—
Apr 5, 2017CORVREVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED—
Jan 31, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 7, 2012CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Mar 7, 2012COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Aug 28, 2011COC.CORRECTION UNDER SECTION 7 - PROCESSED—
Aug 28, 2011APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Aug 24, 2011ES7RTEAS SECTION 7 REQUEST RECEIVED—
Aug 16, 2011R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 1, 2011ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
May 31, 2011NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 31, 2011PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 28, 2011PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Apr 20, 2011CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 20, 2011XAECEXAMINER'S AMENDMENT ENTERED—
Apr 20, 2011GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Apr 20, 2011GNEAEXAMINERS AMENDMENT E-MAILED—
Apr 20, 2011CNEAEXAMINERS AMENDMENT -WRITTEN—
Apr 13, 2011ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Apr 8, 2011PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Mar 29, 2011PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Mar 23, 2011CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 22, 2011DMCCDATA MODIFICATION COMPLETED—
Mar 10, 2011TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 9, 2011CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 9, 2011ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Nov 8, 2010GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Nov 8, 2010GNSLLETTER OF SUSPENSION E-MAILED—
Nov 8, 2010CNSLSUSPENSION LETTER WRITTEN—
Oct 26, 2010XAECEXAMINER'S AMENDMENT ENTERED—
Oct 25, 2010ALIEASSIGNED TO LIE—
Oct 25, 2010GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Oct 25, 2010GNEAEXAMINERS AMENDMENT E-MAILED—
Oct 25, 2010CNEAEXAMINERS AMENDMENT -WRITTEN—
Oct 21, 2010DOCKASSIGNED TO EXAMINER—
Jul 31, 2010MDSCNOTICE OF DESIGN SEARCH CODE MAILED—
Jul 30, 2010NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 30, 2010NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance